tiprankstipranks
Trending News
More News >

Careteq Disputes ATO’s Amended R&D Tax Assessments

Story Highlights
  • Careteq Limited is an Australian healthtech company focused on medication management solutions.
  • Careteq disputes ATO’s amended assessments on R&D claims and plans to object.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Careteq Disputes ATO’s Amended R&D Tax Assessments

Confident Investing Starts Here:

Careteq Ltd. ( (AU:CTQ) ) just unveiled an update.

Careteq Limited has received amended assessments from the Australian Taxation Office regarding its R&D Tax Incentive claims for the financial years ending in 2021, 2022, and 2023, requiring repayment of refunds and interest. The company disputes these assessments and plans to formally object, maintaining confidence in the eligibility of its R&D activities and the validity of its claims, and will engage with the ATO throughout the objection process.

More about Careteq Ltd.

Careteq Limited is an Australian healthtech company focused on innovative medication management solutions. It aims to improve healthcare outcomes through its Embedded Health Solutions and HMR Referrals platforms, providing comprehensive aged care medication management and streamlining Home Medicines Reviews.

Average Trading Volume: 184,283

Technical Sentiment Signal: Strong Sell

See more data about CTQ stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1